Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765578
Status:
COMPLETED
Last Update Posted:
2023-12-22
First Post:
2023-03-09
Brief Title:
An Observational Study of Moderna COVID-19 Bivalent Vaccines Original and Omicron BA4BA5 and 2023 Updated mRNA COVID-19 Vaccines XBB15
Sponsor:
ModernaTX Inc
Organization:
ModernaTX Inc
Study Overview
Official Title:
DisCOVEries 2 - An Observational Study to Evaluate the Immunogenicity of mRNA COVID-19 Bivalent Vaccines Original and Omicron BA4BA5 and 2023 Updated mRNA COVID-19 Vaccines XBB15
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to analyze binding antibody levels in adults in the United States US after receiving coronavirus disease 2019 COVID-19 bivalent boosters original and omicron BA45 and updated COVID-19 vaccines XBB15
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None